Artificial mimicking of physiological active transport by a membrane co-cultured with two different cells: Hepatic origin HepG2 and renal origin PCTL-MDR

Artificial Organs

Volumn 26, Issue 9, 2002, Pages 806-811

  Endo, Mitsufumi ^a   Enosawa, Shin ^a   Ozaki, Michitaka ^a   Tsuruoka, Shuichi ^b   Hiramatsu, Shinya ^c   Kim, Kazumi ^c   Omasa, Takeshi ^c   Matsumura, Toshiharu ^d   Aoki, Tatsuya ^e   Koyanagi, Yasuhisa ^e   Suzuki, Seiichi ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d Roman Industries Co Ltd   (Japan)

^e TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Hemofiltration; HepG2; Multidrug resistance protein; Proximal convoluted tubular cell line

Indexed keywords

CELL DEATH; CONVOLUTION; MEMBRANES; METABOLITES; POLYSACCHARIDES; PROTEINS;

ACTIVE TRANSPORT; CELL LINES; HEMOFILTRATION; HEPG2; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANTS; PROXIMAL CONVOLUTED TUBULAR CELL LINE; SELECTIVE TRANSPORT; TUBULAR CELLS;

CELL CULTURE;

CARBON 14; CYTOCHROME P450 3A4; DIGOXIN; INULIN; MULTIDRUG RESISTANCE PROTEIN; POLITEF; TESTOSTERONE; TOXIN; TRITIUM;

ACTIVE TRANSPORT; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL LINE; CELL MEMBRANE; CELL STRAIN HEPG2; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME METABOLISM; ENZYME SUBSTRATE; HEMOFILTRATION; HUMAN; HUMAN CELL; HYDROXYLATION; IRRADIATION; KIDNEY CELL; KIDNEY PROXIMAL TUBULE; MEMBRANE STABILIZATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 18544377863     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2002.06997.x     Document Type: Article

References (14)

1. Liver transplantation: Current status and novel approaches to liver replacement
2. Bioartificial liver support
3. Bioreactors for hybrid liver support: Historical aspects and novel designs
4. Advances in bioartificial liver devices
5. Coculture of hepatic and renal origin cell lines provides biohemofiltration with an active transport system of metabolites
6. In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure
7. Removal of digoxin and doxorubicin by multidrug resistance protein-overexpressed cell culture in hollow fiber
8. An attempt to add biological functions by genetic engineering in order to produce highperformance bioreactor cells for hybrid artificial liver: Transfection of glutamine synthetase into Chinese hamster ovary (CHO) cell
9. Rac1 regulates stress-induced, redox-dependent heat shock factor activation
10. Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle
11. Xenotransplantation and the risk of retroviral zoonosis
12. Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor with the aim of development for a bioartificial liver
13. General anatomy and histology of the kidney
14. Cytomorphometry of developing rat liver and its application to enzymic differentiation